Whooping cough and RSV vaccines: together or separate in pregnancy
Treatments studied
Part of Infections clinical trials.
This study tests whether giving two vaccines—one for whooping cough (Tdap) and one for RSV—at the same time is safe and effective compared to giving them separately during pregnancy. It may help protect your baby from both diseases early in life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 28 and 30 weeks pregnant with a single baby (no twins).
- You haven't received an RSV vaccine before.
- You haven't had a Tdap (whooping cough) vaccine or a pertussis infection in the last 2 years.
- You are generally healthy and do not have serious health conditions like diabetes, high blood pressure, or problems with your immune system.
- You have no known pregnancy complications like a short cervix, growth problems, or placenta issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new type of whooping cough vaccine given to pregnant women to see if it helps protect their babies from whooping cough in the first months of life. The vaccine is given during pregnancy, and then the baby's immune response is checked up to 15–18 months old.
This study tests whether a second dose of the RSV vaccine during a new pregnancy protects you and your baby from RSV. If you received the RSVpreF or Abrysvo vaccine in a past pregnancy, you may be able to join.
This study tests an approved RSV vaccine given to pregnant women. The goal is to see if it safely protects their babies from severe RSV lung infections during the first months of life.
This registry follows pregnant people who received an RSV vaccine during a specific window (32 to 36 weeks) to monitor safety. If you got the shot in that time, your information helps researchers understand how well the vaccine works in pregnancy.
This study tests two approved ways to prevent RSV, a common virus that can make babies very sick. Pregnant women may get a vaccine, and/or their babies may get an antibody shot after birth. The study compares these options to see which works best.
This study tests a vaccine (called RSVpreF) for pregnant people living with HIV. The vaccine is meant to boost your own immunity so you can pass protection to your baby against RSV, a common and sometimes dangerous respiratory infection.
Hear when a new RSV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.